COVID-19 Treatment Market Analysis - Global Industry Size, Share, Trends and Forecast 2020 - 2027

COVID-19 is an infectious disease caused by a newly discovered coronavirus and is mainly transmitted through droplets generated when an infected person coughs, sneezes, or exhales.

Market Dynamics

Gradual increase in number of cases of corona virus infection and rise in mortality is resulting in demand for advanced treatment which is major factor expected to drive the growth of global covid-19 treatment market. More than 100 million Covid-19 cases have now been recorded worldwide. The United States passed 25 million confirmed cases and the largest death toll of over 420,000. With the rising pandemic effect pharmaceutical manufacturers are investing high for product development and are focused on introduction of enhance vaccine that can cure the covid-19. Government is providing various incentives to enterprises during the pandemic in order to facilitate the production and development of vaccines. High investment by players and introduction of innovative solution from major players is expected to attract the government and consumer further impacting the growth of target market. In 2020, Serum Institute of India, in collaboration with Oxford University developed the fort covid-19 vaccine. The company invested US$ 100 Mn on a potential COVID-19 vaccine. The U.S. government has awarded Novavax US$1.6 Bn to cover testing, commercialization and manufacturing of a potential coronavirus vaccine in the United States. Government of developed and developing countries is focused on increasing the awareness among general population related to treatment of covid-19 and is spending high on the development of effective distribution channel to deliver the effective treatment. In 2020, the US government launched an Operation Warp Speed a covid-19 vaccine program that expects to have up to 100 million doses by the end of the year. According to the Health and Human Services Secretary, the US is also obtaining needles, syringes, bottles and other supplies needed for immunizations. The US President Joe Biden on Tuesday announced the purchase of additional 200 million doses of coronavirus vaccines as the country hit another grim milestone, reaching 25 million infections.

Increasing government spending on development hospital infrastructure with the focus to deliver the advanced care this factor is responsible to support the swift flow of the treatment. Increasing players focus on clinical trials of various solution and efforts to develop various therapies such as plasma therapy and immunotherapy is impacting the growth of covid-19 treatment market. The government of India established the country’s first RBD Plasma Bank and RBD-Coronavirus Antibody Testing Centre set up at Lifeline Blood Bank. Factors such as high cost associated to R&D and manufacturing of the vaccine and lack of advanced healthcare infrastructure in developing countries are major factors expected to hamper the growth of global covid-19 treatment market. In addition, lack of funding and side-effects of the vaccine are factors expected to challenge the growth of covid-19 treatment market. However, increasing government spending on development of present infrastructure and increasing investment by major players for R&D activities and effective development of advanced treatment are factors expected to create new opportunities for players operating in the covid-19 treatment market over the forecast period. In addition, increasing focus on partnership and agreements and favorable business policies by the government is resulting in emergence of small and mid-size enterprises which is expected to support the revenue transaction of the target market.

Segment Analysis by Region

The market in Asia Pacific is expected to account for major revenue share in the global covid-19 treatment market due to increasing government spending on development of healthcare infrastructure. In addition, increasing investment by major players and developing healthcare regulatory scenario are factors expected to support the growth of target market.

In addition, increasing medical tourism in emerging economies and manufacturers approach towards strategic partnership for are factors expected to boost the growth of covid-19 treatment regional market.

Competitive Landscape      

The global covid-19 treatment market is high highly competitive due to presence of large number of players and innovative product offerings. In addition, business expansion activities through partnerships and agreements are factors expected to further increase the competition.

Report coverage

Market	Global COVID-19 Treatment Market
Analysis Period	2016 – 2027
Base Year	2019
Forecast Data	2020 – 2027
Market Stratification	Type, Application, End Use and Geography
Regional Scope	North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
Report Coverage	Market Trends, Drivers, Restraints, Competitive Analysis, Player Profiling, Regulation Analysis

COVID-19 Treatment Market Segment Analysis, 2019

The global covid-19 treatment market is segmented into type, application, and end use. The type segment is bifurcated into life support, antiviral medicine, plasma therapy, immunotherapy, and others. Among type the plasma therapy segment is expected to account for major reasonable revenue share in the target market due to increasing R&D activities on plasma therapy and introduction of innovative solution by major players. The application segment is divided into children and adult. Among the application the adult segment is expected to account for major revenue share in the target market. The players profiled in the report Cadila Healthcare, Johnson & Johnson, ImmunoPrecise, Novartis, AstraZeneca, Cipla, AbbVie, Bayer, Regeneron Pharmaceuticals, and Ascletis Pharma.

Market Segmentation

Market By Type

Life Support

Antiviral Medicine

Plasma Therapy

Immunotherapy

Others

Market By Application

Children

Adult

Market By End Use

Hospital

Clinics

Market By Region

North America

• U.S.
• Canada

Europe

• U.K.
• Germany
• France
• Spain
• Rest of Europe

Asia-Pacific

• China
• Japan
• India
• Australia
• South Korea
• Rest of Asia-Pacific

Latin America

• Brazil
• Mexico
• Rest of Latin America

Middle East & Africa

• GCC
• South Africa
• Rest of Middle East & Africa